The Renol Polychem IPO is set to open for subscription from July 31 to August 4, 2025, aiming to raise approximately ₹25 crore through a fresh issue of shares. Renol Polychem is a leading manufacturer of color masterbatches, pigments, additives, and filler granules primarily serving the plastics processing industry. Established in 2008 and headquartered in Rajkot, Gujarat, the company is known for its high-quality products catering to sectors like packaging, automotive, and agriculture. With advanced blending and compounding technologies, Renol Polychem focuses on innovation and sustainability. The Renol Polychem IPO offers investors an opportunity to participate in a growing plastics additives market with strong fundamentals and expanding clientele.
₹00
₹105
₹105.00
Expert Opinions
The Renol Polychem IPO is receiving favorable market sentiment as investors recognize its strong foothold in the plastics additives industry. The company’s strengths lie in its advanced manufacturing capabilities, innovation-driven product portfolio including color masterbatches and pigments, and diversified clientele across packaging, automotive, and agriculture sectors. Financially, Renol Polychem boasts an impressive Return on Equity (ROE) of 45.37%, a very high Return on Capital Employed (ROCE) of 64.18%, and an EBITDA margin of 11.36% for FY 2025, indicating efficient capital use and healthy profitability.
Risks include raw material price volatility, regulatory impacts on plastic use, and competition from both domestic and international players. From a long-term investment perspective, the Renol Polychem IPO offers promising growth potential driven by increasing plastics demand and innovation focus, making it attractive for investors seeking steady returns in a specialized manufacturing segment with robust fundamentals and growth opportunities.
Investor Considerations
The Renol Polychem IPO reflects a company with strong financial performance and sound fundamentals, reporting a Price to Book Value of 4.32, PAT margin of 8.02%, and a manageable debt-to-equity ratio of 0.52 for FY 2025. Renol Polychem operates in the growing plastics additives sector, offering color masterbatches, pigments, and additives to industries such as packaging, automotive, and agriculture. The sector outlook is positive, driven by rising demand for plastics and sustainable manufacturing solutions.
Growth prospects include scaling production capacity, product innovation, and expanding its customer base. Key risks involve raw material price volatility, regulatory pressures related to plastic usage, and competition from domestic and international players. The IPO suits long-term investors aiming for steady capital appreciation aligned with industry growth, while short-term investors should evaluate market dynamics and sector-specific volatilities carefully. The Renol Polychem IPO offers exposure to a specialized and expanding manufacturing niche with robust fundamentals.
| Date | GMP | Trend |
|---|---|---|
| 06 Aug 2025 10.50 | ₹00 | --- |
| 05 Aug 2025 11.38 | ₹00 | Down |
| 04 Aug 2025 11.50 | ₹10 | --- |
| 02 Aug 2025 20.17 | ₹10 | Down |
| 01 Aug 2025 11.29 | ₹20 | --- |
| 31 Jul 2025 11.48 | ₹20 | Up |
| 30 Jul 2025 11.04 | ₹10 | --- |
| 29 Jul 2025 11.24 | ₹10 | --- |
| 28 Jul 2025 17.30 | ₹10 | --- |
FAQs
The Grey Market Premium showed good accuracy in predicting Renol Polychem IPO’s listing performance. With a final GMP of ₹0, it projected a flat listing at the issue price of ₹105. The stock listed exactly at ₹105, delivering a 0% gain. This resulted in a perfect prediction with 0% error, where the GMP correctly signaled a neutral listing and precisely matched the actual outcome, reflecting strong reliability in this case.
Renol Polychem IPO Current GMP is ₹00.
Renol Polychem IPO Expected Returns is 0.00%.
Renol Polychem IPO estimated listing price is ₹105.